A carregar...

U-500 Regular Insulin: Clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients

OBJECTIVE: To describe the clinical experience and the pharmacokinetics of U-500 regular insulin in severely insulin-resistant obese type 2 diabetic patients. RESEARCH DESIGN AND METHODS: Patients requiring >200 units of insulin with A1C levels >8.0% were switched to U-500 regular insulin. For...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Davidson, Mayer B., Navar, Maria D., Echeverry, Diana, Duran, Petra
Formato: Artigo
Idioma:Inglês
Publicado em: American Diabetes Association 2010
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2809265/
https://ncbi.nlm.nih.gov/pubmed/19910500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc09-1490
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!